Related Experiment Video
Updated: Aug 13, 2026
08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
Ovarian Sertoli-Leydig cell tumor (androblastoma) with retiform pattern. A clinicopathologic study
1Department of Pathology, University of Chicago, IL 60637.
Cancer
|December 15, 1987
Summary
Ovarian Sertoli-Leydig cell tumors with retiform pattern are rare, often misdiagnosed neoplasms. Early recognition is crucial for appropriate treatment and improved patient outcomes.
Area of Science:
- Gynecologic Pathology
- Pediatric Oncology
- Tumor Histology
Background:
- Sertoli-Leydig cell tumors (SLCTs) are rare ovarian neoplasms.
- The retiform pattern is a less common histological subtype of SLCT.
- Accurate diagnosis is essential for appropriate management.
Purpose of the Study:
- To describe the clinicopathologic features of ovarian SLCTs with a retiform pattern.
- To highlight diagnostic challenges and emphasize the importance of recognizing this entity.
Main Methods:
- Retrospective review of nine cases of ovarian SLCT with retiform pattern.
- Analysis of patient demographics, clinical presentation, surgical findings, and histopathology.
- Correlation of serum alphafetoprotein (AFP) levels with disease activity.
Main Results:
- Patients ranged from 11 months to 23 years; most presented with abdominal mass and pain.
- Slight virilization occurred in one patient; elevated serum AFP was noted in two.
- Tumors were unilateral, mostly FIGO Stage I, with a predominant retiform component.
- Three patients developed metastases, with two deaths and one lost to follow-up.
- Six patients remained disease-free for 8 months to 6 years.
Conclusions:
- Ovarian SLCTs with retiform pattern require careful histopathologic evaluation.
- Misdiagnosis as more malignant neoplasms can lead to inappropriate therapy.
- Recognition of this entity is critical for optimal patient management and prognosis.
